Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionAperio Group, LLC
Latest Disclosed Ownership28,753 shares
Latest Disclosed Value $ 752,000
Aperio Group, LLC reports 15.58% increase in ownership of CORT / Corcept Therapeutics Incorporated

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 28,753 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $752,178 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 24,877 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 15.58% during the quarter. The current value of the position is $2,088,043 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 28,753 3,876 15.58 752 73.67 0.0022
2020-11-06 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 24,877 -3,985 -13.81 433 -10.72 0.0015
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 28,862 5,098 21.45 485 71.38 0.0018
2020-05-05 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 23,764 2,982 14.35 283 12.75 0.0013
2020-02-13 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 20,782 -1,984 -8.71 251 -22.05 0.0009
2019-11-06 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 22,766 9,142 67.10 322 111.84 0.0013
2019-07-30 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 13,624 2,460 22.04 152 16.03 0.0006
2019-05-13 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 11,164 -11,708 -51.19 131 -57.19 0.0006
2019-05-06 2018-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 22,872 8,351 57.51 306 50.74 0.0015
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 21,128 6,607 282
2019-05-06 2018-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 14,521 -587 -3.89 203 -14.71 0.0009
2018-10-17 2018-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 14,521 -587 204
2019-05-06 2018-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 15,108 109 0.73 238 -3.25 0.0011
2018-07-30 2018-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 15,108 109 237
2019-05-01 2018-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 14,999 14,999 246 0.0012
2018-05-08 2018-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 14,999 247
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.